Yinu Wang
Cited by
Cited by
Epigenetic targeting of ovarian cancer stem cells
Y Wang, H Cardenas, F Fang, S Condello, P Taverna, M Segar, Y Liu, ...
Cancer research 74 (17), 4922-4936, 2014
FTO-Dependent N6-Methyladenosine Modifications Inhibit Ovarian Cancer Stem Cell Self-Renewal by Blocking cAMP Signaling
H Huang, Y Wang, M Kandpal, G Zhao, H Cardenas, Y Ji, A Chaparala, ...
Cancer research 80 (16), 3200-3214, 2020
Frizzled-7 identifies platinum-tolerant ovarian cancer cells susceptible to ferroptosis
Y Wang, G Zhao, S Condello, H Huang, H Cardenas, EJ Tanner, JJ Wei, ...
Cancer research 81 (2), 384-399, 2021
Therapeutic targeting using tumor specific peptides inhibits long non-coding RNA HOTAIR activity in ovarian and breast cancer
AR Özeş, Y Wang, X Zong, F Fang, J Pilrose, KP Nephew
Scientific reports 7 (1), 894, 2017
The novel, small-molecule DNA methylation inhibitor SGI-110 as an ovarian cancer chemosensitizer
F Fang, J Munck, J Tang, P Taverna, Y Wang, DFB Miller, J Pilrose, ...
Clinical cancer research 20 (24), 6504-6516, 2014
IL-6 mediates platinum-induced enrichment of ovarian cancer stem cells
Y Wang, X Zong, S Mitra, AK Mitra, D Matei, KP Nephew
JCI insight 3 (23), 2018
Metabolic reprogramming from glycolysis to fatty acid uptake and beta-oxidation in platinum-resistant cancer cells
Y Tan, J Li, G Zhao, KC Huang, H Cardenas, Y Wang, D Matei, JX Cheng
Nature communications 13 (1), 4554, 2022
Decitabine reactivated pathways in platinum resistant ovarian cancer
F Fang, Q Zuo, J Pilrose, Y Wang, C Shen, M Li, P Wulfridge, D Matei, ...
Oncotarget 5 (11), 3579, 2014
A novel ALDH1A1 inhibitor targets cells with stem cell characteristics in ovarian cancer
NG Nwani, S Condello, Y Wang, WM Swetzig, E Barber, T Hurley, D Matei
Cancers 11 (4), 502, 2019
Ovarian cancer cell fate regulation by the dynamics between saturated and unsaturated fatty acids
G Zhao, Y Tan, H Cardenas, D Vayngart, Y Wang, H Huang, R Keathley, ...
Proceedings of the National Academy of Sciences 119 (41), e2203480119, 2022
The ratio of toxic-to-Nontoxic mirnas predicts platinum sensitivity in ovarian cancer
M Patel, Y Wang, ET Bartom, R Dhir, KP Nephew, D Matei, AE Murmann, ...
Cancer research 81 (15), 3985-4000, 2021
FOXK2 promotes ovarian cancer stemness by regulating the unfolded protein response pathway
Y Zhang, Y Wang, G Zhao, EJ Tanner, M Adli, D Matei
The Journal of Clinical Investigation 132 (10), 2022
Metabolic dependencies and targets in ovarian cancer
Y Zhang, Y Wang, G Zhao, S Orsulic, D Matei
Pharmacology & Therapeutics, 108413, 2023
Loss of host tissue transglutaminase boosts antitumor T cell immunity by altering STAT1/STAT3 phosphorylation in ovarian cancer
LE Sima, S Chen, H Cardenas, G Zhao, Y Wang, C Ivan, H Huang, ...
Journal for immunotherapy of cancer 9 (9), 2021
Relationships among Rubus (Rosaceae) Species used in Traditional Chinese Medicine
Y Wang
N6-Methyladenosine RNA modifications regulate the response to platinum through nicotinamide N-methyltransferase
H Huang, G Zhao, H Cardenas, AF Valdivia, Y Wang, D Matei
Molecular cancer therapeutics 22 (3), 393-405, 2023
DOT1 L regulates ovarian cancer stem cells by activating β-catenin signaling
Y Zhang, Y Wang, A Valdivia, H Huang, D Matei
Molecular Cancer Research 21 (2), 140-154, 2023
Biology-driven therapy advances in high-grade serous ovarian cancer
Y Wang, AJ Duval, M Adli, D Matei
The Journal of Clinical Investigation 134 (1), 2024
Abstract A57: Platinum induces IL-6-signaling mediated activation of ALDH1A1 and enriches the cancer stem cell population in ovarian cancer.
Y Wang, AK Mitra, KP Nephew
Clinical Cancer Research 22 (2_Supplement), A57-A57, 2016
Epigenetic Targeting of Ovarian Cancer Stem Cells
KP Nephew, Y Wang, H Cardenas, F Fang, S Condello, P Taverna, ...
Cancer Res, 2014
The system can't perform the operation now. Try again later.
Articles 1–20